Follow
Roberto Palacios-Ramirez
Roberto Palacios-Ramirez
Other namesRoberto Palacios-Ramírez, Roberto Palacios
Postdoc, IBGM/Universidad de Valladolid, Valladolid, Spain
Verified email at uva.es - Homepage
Title
Cited by
Cited by
Year
Toll‐like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II‐induced hypertension
R Hernanz, S Martínez‐Revelles, R Palacios, A Martin, V Cachofeiro, ...
British journal of pharmacology 172 (12), 3159-3176, 2015
1582015
Toll-like receptor 4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production
PR De Batista, R Palacios, A Martin, R Hernanz, CT Medici, MASC Silva, ...
PloS one 9 (8), e104020, 2014
1252014
Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor
C Lefranc, M Friederich-Persson, R Palacios-Ramirez, AND Cat
Journal of Endocrinology 238 (3), R143-R159, 2018
672018
Role of COX‐2‐derived PGE2 on vascular stiffness and function in hypertension
MS Avendaño, S Martinez‐Revelles, A Aguado, MR Simões, ...
British journal of pharmacology 173 (9), 1541-1555, 2016
672016
NADPH oxidase 5 is a pro‐contractile Nox isoform and a point of cross‐talk for calcium and redox signaling‐implications in vascular function
AC Montezano, L De Lucca Camargo, P Persson, FJ Rios, AP Harvey, ...
Journal of the American Heart Association 7 (12), e009388, 2018
652018
Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative …
A Martin, JV Perez-Giron, R Hernanz, R Palacios, AM Briones, A Fortuno, ...
Journal of hypertension 30 (2), 315-326, 2012
632012
MR (mineralocorticoid receptor) induces adipose tissue senescence and mitochondrial dysfunction leading to vascular dysfunction in obesity
C Lefranc, M Friederich-Persson, L Braud, R Palacios-Ramirez, ...
Hypertension 73 (2), 458-468, 2019
542019
Aluminum exposure at human dietary levels promotes vascular dysfunction and increases blood pressure in rats: a concerted action of NAD (P) H oxidase and COX-2
CS Martinez, JT Piagette, AG Escobar, Á Martín, R Palacios, FM Peçanha, ...
Toxicology 390, 10-21, 2017
432017
Cutaneous wound healing in diabetic mice is improved by topical mineralocorticoid receptor blockade
N Farman, R Palacios-Ramirez, M Sbeih, F Behar-Cohen, S Aractingi, ...
Journal of Investigative Dermatology 140 (1), 223-234. e7, 2020
402020
Spironolactone prevents endothelial nitric oxide synthase uncoupling and vascular dysfunction induced by β-adrenergic overstimulation: role of perivascular adipose tissue
JA Victorio, SP Clerici, R Palacios, MJ Alonso, DV Vassallo, IZ Jaffe, ...
Hypertension 68 (3), 726-735, 2016
392016
Pioglitazone treatment increases COX‐2‐derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function
R Hernanz, Á Martín, JV Pérez‐Girón, R Palacios, AM Briones, M Miguel, ...
British journal of pharmacology 166 (4), 1303-1319, 2012
342012
Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats
JV Pérez-Girón, R Palacios, A Martin, R Hernanz, A Aguado, ...
American Journal of Physiology-Heart and Circulatory Physiology 306 (11 …, 2014
282014
Cholesteryl ester-transfer protein inhibitors stimulate aldosterone biosynthesis in adipocytes through Nox-dependent processes
FJ Rios, KB Neves, AND Cat, S Even, R Palacios, AC Montezano, ...
Journal of Pharmacology and Experimental Therapeutics 353 (1), 27-34, 2015
272015
Pioglitazone modulates the vascular contractility in hypertension by interference with ET-1 pathway
R Palacios-Ramírez, R Hernanz, A Martín, JV Pérez-Girón, MT Barrús, ...
Scientific Reports 9 (1), 16461, 2019
232019
Egg White Hydrolysate: A new putative agent to prevent vascular dysfunction in rats following long-term exposure to aluminum
CS Martinez, JT Piagette, AG Escobar, Á Martín, R Palacios, FM Peçanha, ...
Food and Chemical Toxicology 133, 110799, 2019
192019
Mineralocorticoid receptor antagonism prevents the synergistic effect of metabolic challenge and chronic kidney disease on renal fibrosis and inflammation in mice
R Palacios-Ramirez, I Lima-Posada, B Bonnard, M Genty, ...
Frontiers in Physiology 13, 859812, 2022
122022
Egg white hydrolysates improve vascular damage in obese Zucker rats by its antioxidant properties
M Garcés‐Rimón, C González, R Hernanz, E Herradón, A Martín, ...
Journal of food biochemistry 43 (12), e13062, 2019
82019
Benefits of the non-steroidal mineralocorticoid receptor antagonist finerenone in metabolic syndrome-related heart failure with preserved ejection fraction
I Lima-Posada, Y Stephan, M Soulié, R Palacios-Ramirez, B Bonnard, ...
International Journal of Molecular Sciences 24 (3), 2536, 2023
72023
Peroxisome proliferator-activated receptor-c activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative …
A Martın, JV Pérez-Girón, R Hernanz, R Palacios, AM Briones, A Fortuno
J Hypertens 30 (2), 315-326, 2012
72012
Involvement of Bcl-2 family proteins in tetraploidization-related senescence
D Barriuso, L Alvarez-Frutos, L Gonzalez-Gutierrez, O Motiño, G Kroemer, ...
International journal of molecular sciences 24 (7), 6374, 2023
62023
The system can't perform the operation now. Try again later.
Articles 1–20